OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neuro-Oncology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival	55
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review	48
A practical guide to neuro-oncology fellowship	39
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management	38
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	37
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection	37
Factors influencing timely diagnosis in neurolymphomatosis	36
Prognostic factors among patients with brain metastases from cancer of unknown primary site	34
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma	34
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor	33
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence	33
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study	32
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease	32
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience	32
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas	30
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy	29
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu	28
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma	28
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma	28
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update	28
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review	28
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review	26
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival	26
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma	26
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities	26

Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population	26
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis	26